Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
暂无分享,去创建一个
[1] A. Ashworth,et al. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers , 2010, Breast Cancer Research and Treatment.
[2] R. Medema,et al. Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition , 2010, Oncogene.
[3] E. Yu,et al. Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation* , 2010, The Journal of Biological Chemistry.
[4] R. Gatti,et al. ATM is down-regulated by N-Myc–regulated microRNA-421 , 2010, Proceedings of the National Academy of Sciences.
[5] Xiongbin Lu,et al. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. , 2009, Cancer research.
[6] Hiroshi I. Suzuki,et al. Modulation of microRNA processing by p53 , 2009, Nature.
[7] W. V. van IJcken,et al. MicroRNA‐mediated gene silencing modulates the UV‐induced DNA‐damage response , 2009, The EMBO journal.
[8] A. Ashworth,et al. Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers , 2009, Clinical Cancer Research.
[9] Ettore Appella,et al. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites , 2008, Nucleic acids research.
[10] Mauro Biffoni,et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.
[11] Daniel Medina,et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. , 2008, Cancer research.
[12] A. Ashworth,et al. A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D , 2008, Oncogene.
[13] Yolanda F. Darlington,et al. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.
[14] Xiongbin Lu,et al. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.
[15] L. Donehower,et al. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D , 2007, Journal of Neuro-Oncology.
[16] S. Semba,et al. Increased wild‐type p53‐induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma , 2007, Pathology international.
[17] E. Appella,et al. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis , 2007, Oncogene.
[18] S. Hirohashi,et al. Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome , 2007, Cancer science.
[19] E. Appella,et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.
[20] A. Hoischen,et al. Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components , 2006, The Journal of pathology.
[21] Päivikki Kauraniemi,et al. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours , 2006, Breast Cancer Research and Treatment.
[22] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Donehower,et al. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.
[24] L. Donehower,et al. Reversal of the ATM/ATR-Mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D , 2005, Cell cycle.
[25] L. Donehower,et al. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. , 2004, Molecular cell.
[26] G. Dontu,et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.
[27] L. Donehower,et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.
[28] G. Dontu,et al. Stem cells in normal breast development and breast cancer , 2003, Cell proliferation.
[29] J. Inazawa,et al. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[31] Akira Nakagawara,et al. PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.
[32] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[34] Jeffrey R. Marks,et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.
[35] Lawrence A. Donehower,et al. Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle Control , 2002, Molecular and Cellular Biology.
[36] Masaaki Adachi,et al. p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.
[37] N. D. Kim,et al. Stem cell characteristics of transplanted rat mammary clonogens. , 2000, Experimental cell research.
[38] M. Fiscella,et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.